-+ 0.00%
-+ 0.00%
-+ 0.00%

ROCHE CANADA: HEALTH CANADA APPROVES (PR)OCREVUS® (OCRELIZUMAB) FOR TREATING PEDIATRIC RELAPSING-REMITTING MULTIPLE SCLEROSIS

Reuters·11/03/2026 14:05:35

Please log in to view news